- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.02. | Biogen axes asset from $7.3B buyout, along with Alzheimer's and Parkinson's prospects | ||
| 12.02. | AbbVie signs heavily backloaded $2.1B Xilio biobucks pact in Big Pharma's latest T-cell engager deal | ||
| 12.02. | Sanofi-backed Abcuro raises $200M series C to fund pivotal trial of KLRG1 antibody | ||
| 12.02. | Biogen enlists Royalty for pursuit of lupus crown, securing $250M to fund phase 3 program | ||
| 11.02. | Inspire Medical discloses DOJ civil false claims investigation | ||
| 11.02. | Pfizer's investigational candidate combo cuts prostate cancer progression by 49% in phase 1 | ||
| 11.02. | Journey of Voyager's ALS gene therapy to clinic hindered by need to find alternative payload | ||
| 11.02. | Third Harmonic halves headcount to take urticaria drug into phase 2 despite side effects | ||
| 11.02. | Incyte exits immuno-oncology pact, leaving Agenus weighing options for assets | ||
| 11.02. | Inventiva lays off 50% of staff to go all-in on MASH drug | ||
| 11.02. | Novartis inks $925M Anthos takeover to buy back phase 3 clot-busting candidate | ||
| 11.02. | Q32 Bio sticks with bempikibart, but loses staff and phase 2 complement inhibitor | ||
| 10.02. | DNA sequencing shares slide amid 'headwinds' from Trump's NIH funding cuts | ||
| 10.02. | NIH caps 'indirect costs' in biomedical research grants, aims to save $4B per year | ||
| 10.02. | FDA amplifies BD atherectomy safety alert following 4 deaths | ||
| 10.02. | Globus Medical to buy neurostim developer Nevro for $250M | ||
| 10.02. | Boehringer widens fibrosis drug's approval path after boosting lung function in 2nd phase 3 trial | ||
| 10.02. | Eli Lilly inks duo of deals, teaming with AdvanCell, OliX to push deeper into radiopharma, MASH | ||
| 10.02. | Kineta sells Genentech and Merck deals to investor ahead of TuHURA merger | ||
| 10.02. | Pliant pauses phase 2 lung fibrosis trial on advice of safety committee | ||
| 07.02. | New AI-discovered protein compounds kill bacteria and fungi infecting mice: study | ||
| 07.02. | eGenesis announces 2nd pig kidney procedure success, as xenotransplantation field moves forward | ||
| 07.02. | Illumina posts mixed earnings report while dealing with China tariff fallout | ||
| 07.02. | After phase 3 miss, Relmada picks up midstage Tourette's asset from Swedish biotech | ||
| 07.02. | Bristol Myers backs out of Dupixent fight, axing allergy asset despite phase 3 win |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
